Washington needs to stop trying to force companies to stay in the US and address the real problem, says Edward J. Reilly of FTI Consulting.» Read More
CEOs of big drug companies are rarely, if ever, publicly candid about the price of their stock. You usually get the boilerplate line about how they manage the business and the market will do whatever.
General Motors Chief Rick Wagoner, Chrysler's Robert Nardelli and before he stepped aside, Yahoo's Jerry Yang -- are just a few CEOs that have spent the past year under siege. As we watch CEOs stagger from the incredibly poor decision-making, it is easy to think that we are the unwitting victims who will endure losses because of their errors.
Key FCC rulings could hurt this company, and the stock's already down since the summer. So is the dividend safe?
Not even a horrible market will keep this steelmaker from upping its payout, it seems. Was that the right move?
Commentary: All of America now can rest easy: Merrill Lynch chief John Thain won’t get his $10 million bonus after all, having succumbed to browbeating calls for fiscal restraint.
Here's Michelle's guest blog on why Thain should be rewarded for shepherding Merrill Lynch through an awful year, as the company was eventually taken over by Bank of America.
Analysts have a one-day respite between two major pharma R & D days and they're using it to size up Merck's update yesterday and to set expectations for Eli Lilly's briefing tomorrow.
Does coal work as an investment during a Barack Obama administration?
I wrote this morning's post from the Merck analyst meeting before sitting down for my exclusive interview with Exec Veep Ken Frazier. So, I had to pass along this fresh anecdote that illustrates even more how far this drug company and its people have come.
Sitting here at Merck's annual drug research and development for the Street in the media room at the company's headquarters in central New Jersey. This year, for the first time, MRK is allowing reporters into the actual meeting room with the 300 or so analysts and investors
How can a company raise its dividend and at the same lower guidance? That's what Cramer wanted to know.
Rep. Barney Frank discusses the auto bailout issue, while New York Attorney General Andrew Cuomo says a $10 million bonus for Merrill Lynch's John Thain is unjustified. Following are today's top videos:
The drum beats calling for Rick Wagoner's head, or at least his job, are becoming louder. What started last week with critics and commentators saying any bailout should include new leadership at the Big 3, now has spread to political leaders saying it may be time for some of the auto leadership to change.
Cramer talks to the cheif exec about this, er, nutty market.
If you watched the Big 3 CEOs on Capitol Hill Thursday you probably came away with two impressions. First, the contrite tone of the CEOs makes it clear the auto makers know they have to try a more humbled approach.
With the stock trading at just under $2, Cramer thinks there's no longer a point in tracking this CEO.
Are we better or worse off than we were a year ago?
The Big Three CEOs returned to Washington to meet with the Senate Banking Committee today, as AT&T and other companies reported job cuts. Following are today's top videos:
Earlier this week UBS pharmaceutical analyst Roopesh Patel put out a big 2009 sector outlook research note claiming, "So far, the global economic slowdown has had no noticeable impact — a) U.S. weekly and monthly U.S. prescription trends are stable; b) there also is no meaningfully cautionary commentary from any of the companies...." Well, he might have spoken too soon.
Plus, Cramer makes the call on Yahoo! and Freeport-McMoRan.